EFSA Establishes Provisional Safe Level for Cannabidiol as Novel Food

EU food safety agency sets guidelines for CBD products, highlights data gaps

Published on Feb. 9, 2026

The European Food Safety Authority (EFSA) has established a provisional safe intake level of 0.0275 milligrams per kilogram of body weight per day for cannabidiol (CBD) as a novel food. However, EFSA noted persistent data gaps regarding potential effects on the liver, endocrine, nervous and reproductive systems, and said the safety of CBD cannot be established for individuals under 25, pregnant/lactating women, and those on medication.

Why it matters

This EFSA guidance is an important step in regulating the burgeoning CBD market in Europe, providing a framework for safe consumption levels while highlighting the need for more research on potential health impacts. The provisional safe level aims to protect public health despite data uncertainties, and will inform novel food applications and approvals.

The details

EFSA's expert panel set the provisional safe intake level for CBD-containing food supplements with at least 98% purity and no nanoparticles, provided the production process is deemed safe. However, the agency said safety cannot be assured for certain vulnerable populations. EFSA plans to review the provisional level once more data becomes available from applicants or published research.

  • EFSA published the updated statement on February 9, 2026.
  • EFSA previously highlighted data gaps in a statement on June 7, 2022.
  • EFSA plans to hold a follow-up webinar for applicants in April 2026.

The players

European Food Safety Authority (EFSA)

The European Union's agency responsible for risk assessment and communication on food and feed safety.

European Commission

The executive branch of the European Union, which considers CBD a novel food under EU legislation.

Got photos? Submit your photos here. ›

What’s next

EFSA will proceed with risk assessments of individual CBD novel food applications based on data provided by applicants.

The takeaway

This EFSA guidance aims to responsibly regulate the CBD market in Europe by establishing a provisional safe intake level, while highlighting the need for more research to address persistent data gaps and ensure the safety of CBD for all consumers.